Propensity score analysis of early and late outcome after redo off-pump and on-pump coronary artery bypass grafting

Propensity score analysis of early and late outcome after redo off-pump and on-pump coronary artery bypass grafting

The purpose of this study was to compare early and late results of redo-CABG with (redo-ONCAB) and without (redo-OPCAB) cardiopulmonary bypass. 

Methods: From April 2001 to September 2006 redo-CABG was performed in 110 patients (redo-ONCAB = 50 and redo-OPCAB = 60). Applying the propensity score, 43 OPCAB patients were matched with 43 ONCAB patients. The mean EuroScore was 5 ± 4.7 and 5 ± 3.4 for redo-ONCAB and redo-OPCAB, respectively (p = 0.5). The number of diseased coronary arteries was 3 ± 0.5 and 2 ± 0.8 in redo-ONCAB and redo-OPCAB, respectively (p < 0.01). 

Results: Twelve patients underwent OPCAB through anterior thoracotomy while the rest of the patients (n = 74) underwent median sternotomy. Mean number of grafts performed was 3 ± 0.8 in redo-ONCAB and 2 ± 0.6 in redo-OPCAB (p < 0.05). The need for postoperative insertion of intra-aortic balloon pump (IABP) was higher (p = 0.02) in redo-ONCAB (n = 9, 21%) than redo-OPCAB (n = 1, 2%). The duration of postoperative ventilation was 55 ± 98.7 h for redo-ONCAB and 10 ± 12.8 h for redo-OPCAB (p = 0.008). No differences were found in the incidence of other postoperative complications. The 30-day mortality rate was 6.9% for redo-ONCAB (n = 3) and 2.3% redo-OPCAB (n = 1; p = NS). Mean follow-up for redo-ONCAB was 30 ± 21.3 months (range 0.1–63 months) and that of redo-OPCAB was 37 ± 19.2 months (0.1–62.5 months). Actuarial survival at 5 years was 87 ± 5.5% for redo-ONCAB and 95 ± 3.2% for redo-OPCAB (p = 0.17). Event-free survival was 71 ± 8.0% for redo-ONCAB and 78 ± 7.2% for redo-OPCAB (p = 0.32). 

Conclusion: OPCAB is an acceptable strategy in selected patients requiring redo-CABG. Employing a strategy of OPCAB for those patients with 2 or fewer lesions and ONCAB for those with more diffuse disease, redo-OPCAB and redo-ONCAB have similar early and late outcomes.

Leave a Reply

Your email address will not be published. Required fields are marked *

Office Address
John Radcliffe Hospital
Headley Way, Headington, Oxford, OX3 9DU380
Manor Hospital
Beech Road, Headington, Oxford, OX3 7RP United Kingdom
OFFICE Hours
By appointment
Message Us
For any problems or questions, please email me: shakil.farid74(at)gmail.com